Experimental drug may work against hepatitis C
(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.
Diseases, Conditions, Syndromes
Mar 27, 2013 |
5 / 5 (3) |
1
|
Carmustine decreases amyloid beta plaques
Long term treatment by carmustine, a chemical relative of mustard gas and already used to treat some types of brain cancer, can decrease the amount of amyloid β and number of amyloid plaques in a mouse model of Alzheimer's ...
Alzheimer's disease & dementia
Mar 25, 2013 |
5 / 5 (1) |
0
Study reveals new approach for stopping herpes infections
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes responsible for causing genital ...
Diseases, Conditions, Syndromes
Mar 25, 2013 |
5 / 5 (2) |
0
|
Pain reliever naproxen shows anti-viral activity against flu
The over-the-counter anti-inflammatory drug naproxen may also exhibit antiviral activity against influenza A virus, according to a team of French scientists. The finding, the result of a structure-based investigation, is ...
Medications
Mar 21, 2013 |
5 / 5 (1) |
0
|
Fight back against MRSA to be started with a sniff
An innovative anti-bacterial spray that will kill MRSA is being developed by Norwich Research Park scientists thanks to funding from the University of East Anglia.
Diseases, Conditions, Syndromes
Mar 21, 2013 |
not rated yet |
0
Malaria vaccine fails to work after four years
A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday.
Medications
Mar 20, 2013 |
1 / 5 (1) |
0
Studies for approval of new drugs have insufficient patients to evaluate safety
For medicines intended for chronic use, the number of patients studied before regulatory approval is insufficient to properly evaluate safety and long-term efficacy, requiring the need for new legislation, according to a ...
Medications
Mar 19, 2013 |
not rated yet |
0
Study could aid development of new drugs to treat gout
Findings from a Loyola University Chicago Stritch School of Medicine study could lead to the development of new drugs to treat gout. The study, led by Liang Qiao, MD, and his colleagues and collaborators, was published March ...
Immunology
Mar 19, 2013 |
5 / 5 (2) |
0
|
A combined approach needed to fight antibiotics resistance, research says
(Medical Xpress)—In her latest report to the government, Professor Dame Sally Davies - the UK's Chief Medical Officer - says the current antibiotics resistance crisis poses a "catastrophic threat". ...
Medications
Mar 15, 2013 |
4.5 / 5 (2) |
0
|
Artificial human livers engineered for drug testing and discovery
The liver is an important target organ for drug testing because all drugs pass through it for detoxification. This is a process whereby harmful substances are reduced or removed from the body. Drugs that cannot be detoxified ...
Medical research
Mar 15, 2013 |
5 / 5 (2) |
0
Aggressive regimen reduces mortality in drug-resistant TB
(Medical Xpress)—Aggressive drug regimens used to treat multidrug-resistant tuberculosis reduce the risk of death by about 40 percent when they include at least five drugs likely to be effective against ...
Diseases, Conditions, Syndromes
Mar 15, 2013 |
not rated yet |
0
|
FDA wants to relax approval process for Alzheimer's drugs
(HealthDay)—In an effort to quickly develop drugs that could prevent or slow Alzheimer's, the U.S. Food and Drug Administration said it plans to relax the approval process for experimental medications for ...
Alzheimer's disease & dementia
Mar 14, 2013 |
5 / 5 (1) |
0
Rules must evolve to allow new drugs for early Alzheimer's
(HealthDay)—Given the shift in the focus of drug development for Alzheimer's disease toward earlier disease stages, before the onset of dementia, regulatory guidelines need to evolve, according to a perspective ...
Alzheimer's disease & dementia
Mar 14, 2013 |
4 / 5 (2) |
0
New drugs might give heart patients an edge
(HealthDay)—In the search for better medicines to safely help heart patients, clinical trials testing three new drugs appear to offer some promise.
Cardiology
Mar 11, 2013 |
4 / 5 (1) |
0
New anti-clotting drug more effective than current treatment
A new and experimental anti-clotting drug, cangrelor, proved better than the commonly used clopidogrel and was significantly more effective at preventing blood clots in a large trial of patients who underwent coronary stent ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
